CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Subscribe

How does it work

CPHI Online is a global marketplace.

The place where global Pharma professionals come to source new partners, look for products and solutions and make connections – all year round. It’s also a go-to place to learn about the latest trends, developments and news in the Pharma industry.

If your company wants to do business with the global Pharma industry, this is the place to be.

Why CPHI Online

CPHI Online is the largest global marketplace where the pharma community comes to source new partners, showcase products and solutions, and make connections.

Direct access to your target Pharma audience
Effective reporting
Multi or single channel campaigns
Measurable communications and results
Scalable multi-channel campaigns
Build brand credibility
Generate leads
Access to expert analysts
Promotional campaign around your content
Innovative and memorable content

Trusted by over 7,000 pharma companies, including:

Top Products

CPHI Pharmaceutical Products, Companies and News

The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains

News The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains

About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es...

AstraZeneca shares plunge 8.9% after reports of BMS talks

News AstraZeneca shares plunge 8.9% after reports of BMS talks

Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem...

GSK announces £400 million investment in new Cambridge R&D centre

News GSK announces £400 million investment in new Cambridge R&D centre

Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration